Document Detail


Neuroprotective effects of estrogens following ischemic stroke.
MedLine Citation:
PMID:  19401209     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Our laboratory has investigated whether and how 17beta-estradiol (E(2)) protects the brain against neurodegeneration associated with cerebrovascular stroke. We have discovered that low, physiological concentrations of E(2), which are strikingly similar to low-basal circulating levels found in cycling mice, dramatically protect the brain against stroke injury, and consequently revealed multiple signaling pathways and key genes that mediate protective action of E(2). Here we will review the discoveries comprising our current understanding of neuroprotective actions of estrogens against ischemic stroke. These findings may carry far reaching implications for improving the quality of life in aging populations.
Authors:
Shotaro Suzuki; Candice M Brown; Phyllis M Wise
Related Documents :
16310049 - Effects of 17beta-estradiol on the maturation, nuclear factor kappa b p65 and functions...
19281799 - Divergent effects of estradiol and the estrogen receptor-alpha agonist ppt on eating an...
3651519 - Postnatal development of uterine abnormalities in mice exposed to des in utero.
17010099 - Involvement of estrogen receptor alpha, beta and oxytocin in social discrimination: a d...
851139 - Effect of prenatal treatment with ethinyl estradiol on the mouse uterus and ovary.
19439729 - Impaired estrogen feedback and infertility in female mice with pituitary-specific delet...
7323419 - Glomerular permeability: alteration in size- and charge-based barrier function in lupus...
8881659 - Interleukin-1 but not tumour necrosis factor alpha synergistically upregulates the gran...
12035549 - Plasmid mediated expression of human growth hormone increases splenocytes proliferative...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2009-05-03
Journal Detail:
Title:  Frontiers in neuroendocrinology     Volume:  30     ISSN:  1095-6808     ISO Abbreviation:  Front Neuroendocrinol     Publication Date:  2009 Jul 
Date Detail:
Created Date:  2009-06-23     Completed Date:  2009-08-17     Revised Date:  2011-04-21    
Medline Journal Info:
Nlm Unique ID:  7513292     Medline TA:  Front Neuroendocrinol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  201-11     Citation Subset:  IM    
Affiliation:
Departments of Physiology and Biophysics, and Biology, University of Washington, Seattle, WA 98195-1237, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Inflammatory Agents* / metabolism,  pharmacology,  therapeutic use
Brain Ischemia / drug therapy*,  pathology
Estrogen Receptor alpha / metabolism
Estrogen Replacement Therapy
Estrogens* / metabolism,  pharmacology,  therapeutic use
Hippocampus / cytology,  growth & development
Humans
Inflammation / metabolism
Nerve Growth Factors / metabolism
Nerve Regeneration / drug effects
Neurogenesis / drug effects
Neuroprotective Agents* / metabolism,  pharmacology,  therapeutic use
Receptors, Glutamate / metabolism
Stroke / drug therapy*,  pathology,  prevention & control
Grant Support
ID/Acronym/Agency:
AG 27614/AG/NIA NIH HHS; AG02224/AG/NIA NIH HHS; AG17164/AG/NIA NIH HHS; F32 AG027614-02/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Anti-Inflammatory Agents; 0/Estrogen Receptor alpha; 0/Estrogens; 0/Nerve Growth Factors; 0/Neuroprotective Agents; 0/Receptors, Glutamate; 0/estrogen receptor alpha, human

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior.
Next Document:  Studying the effectiveness of penetration enhancers to deliver retinol through the stratum cornum by...